Recombinant Human Follicle Stimulating Hormone(Beijing Sl)

重组人卵泡刺激素（双鹭药业）

Report date: 2023/05/26 20:00:27

Base Information

Drug NameRecombinant Human Follicle Stimulating Hormone(Beijing Sl)
Drug Alias Name长效重组人促卵泡激素（北京双鹭药业）
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, FemaleAnovulation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility, FemaleAnovulation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A